Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CYLD antibody (AA 501-600)

The Rabbit Polyclonal anti-CYLD antibody has been validated for WB, ELISA, IHC (p), FACS, IF (cc), IF (p) and IHC (fro). It is suitable to detect CYLD in samples from Human, Mouse and Rat.
Catalog No. ABIN750158

Quick Overview for CYLD antibody (AA 501-600) (ABIN750158)

Target

See all CYLD Antibodies
CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))

Reactivity

  • 44
  • 21
  • 16
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Mouse, Rat

Host

  • 37
  • 7
  • 1
Rabbit

Clonality

  • 38
  • 7
Polyclonal

Conjugate

  • 21
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CYLD antibody is un-conjugated

Application

  • 30
  • 13
  • 9
  • 5
  • 5
  • 4
  • 4
  • 3
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Binding Specificity

    • 15
    • 7
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 501-600

    Cross-Reactivity

    Human, Mouse, Rat

    Predicted Reactivity

    Cow,Horse,Chicken

    Purification

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic peptide derived from human cylindromatosis 1

    Isotype

    IgG
  • Application Notes

    WB 1:300-5000
    ELISA 1:500-1000
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))

    Alternative Name

    CYLD

    Background

    Synonyms: CDMT, cylindromatosis turban tumor syndrome, cylindromatosis 1, Deubiquitinating enzyme CYLD, EAC, HSPC057, KIAA0849, turban tumor syndrome, Ubiquitin thiolesterase CYLD, Ubiquitin-specic processing protease CYLD, CYLD_HUMAN, Ubiquitin carboxyl-terminal hydrolase CYLD, CYLD, BRSS, CDMT, CYLD1, CYLDI, EAC, MFT, MFT1, SBS, TEM, USPL2.

    Background: Defects in CYLD are the cause of familial cylindromatosis (CYLD) also known as turban tumor syndrome or dermal eccrine cylindromatosis. CYLD is an autosomal dominant and highly tumor type-specific disorder. The tumors (known as cylindromas because of their characteristic microscopic architecture) are believed to arise from or recapitulate the appearance of the eccrine or apocrine cells of the skin that secrete sweat and scent respectively. Cylindromas arise predominantly in hairy parts of the body with approximately 90 % on the head and neck. The development of a confluent mass which may ulcerate or become infected has led to the designation "turban tumor syndrome". The skin tumors show differentiation in the direction of hair structures, hence the synonym trichoepithelioma. CYLD has deubiquitinating activity.

    Gene ID

    1540

    Pathways

    Apoptosis, Activation of Innate immune Response
You are here:
Chat with us!